You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Biosimilars Show Their Muscle as Emerging Pharmaceutical Phenomenon

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 147 Words
Attachment: Biosimilar Heat Map, May 2018

SUGAR LAND--May 17, 2018--Researched by Industrial Info Resources (Sugar Land, Texas)--Almost the same, but not quite--a biosimilar is just that, similar but not equal to an original biological drug. Unlike generics, biological drugs are too complex be duplicated. And the market for biosimilars is definitely worth watching. Industrial Info is tracking nearly $2 billion worth of active biosimilar facility projects worldwide.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00